This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Unhealthy dietary patterns are among the leading drivers of the global health crisis, significantly contributing to rising rates of obesity, cardiovascular disease (CVD) and type 2 diabetes (T2D). Nutritional science has long established that the quality of fat in our diet is crucial for metabolic health. Reducing saturated fat intake or replacing it with unsaturated fats has been shown to lower CVD and T2D risk by improving blood lipid profiles and reducing inflammation. While traditional blood lipid profiles focus on key markers like cholesterol, advanced lipidomics provides a comprehensive view of the entire circulating lipidome, uncovering specific changes in lipid classes.
New findings from an intervention and cohort study suggest that the fatty acids provided by peanuts do more than just contribute calories. Researchers at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), together with colleagues at the University of Barcelona, have demonstrated that a specific "Peanut Lipidomic Signature" (PeLS) is associated with a reduction in the risk of type 2 diabetes. The study was published in The American Journal of Clinical Nutrition, and reveals how peanut consumption triggers a measurable remodeling of the human lipidome.
Saturated fatty acids (FA) are not a homogeneous group. Very-long-chain saturated fatty acids (VLCSFA)—comprising chains of more than 20 carbon atoms—are thought to exert unique metabolic effects. As a primary dietary source of both VLCSFA and monounsaturated FA, peanuts—botanically classified as legumes—have a distinctive FA profile.
Source link







